Cephradine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cephradine and what is the scope of patent protection?

Cephradine is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Barr, Ivax Sub Teva Pharms, Teva, Vitarine, Apothecon, Ersana, and Bristol Myers Squibb, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for cephradine

US Patents:	0
Tradenames:	6
Applicants:	8
NDAs:	15
Drug Master File Entries:	10
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	8,255
DailyMed Link:	cephradine at DailyMed

Medical Subject Heading (MeSH) Categories for cephradine

Anti-Bacterial Agents

US Patents and Regulatory Information for cephradine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	VELOSEF '125'	cephradine	FOR SUSPENSION;ORAL	061763-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Ersana	VELOSEF '500'	cephradine	CAPSULE;ORAL	050548-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Glaxosmithkline	ANSPOR	cephradine	CAPSULE;ORAL	061859-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Apothecon	VELOSEF	cephradine	INJECTABLE;INJECTION	061976-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Apothecon	VELOSEF	cephradine	INJECTABLE;INJECTION	061976-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva	CEPHRADINE	cephradine	CAPSULE;ORAL	062683-002	Jan 9, 1987		DISCN	No	No
Vitarine	CEPHRADINE	cephradine	CAPSULE;ORAL	062813-001	Feb 25, 1988		DISCN	No	No